<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1289">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04351919</url>
  </required_header>
  <id_info>
    <org_study_id>ECC2020-04</org_study_id>
    <nct_id>NCT04351919</nct_id>
  </id_info>
  <brief_title>Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)</brief_title>
  <acronym>COVID+PA</acronym>
  <official_title>Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+), inTunisia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abderrahmane Mami Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eshmoun Clinical Research Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dacima Consulting</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Abderrahmane Mami Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will assess the number of patients who become asymptomatic from clinical signs of
      COVID19 and will assess the efficacy of Hydroxychloroquine (HCQ) and Azithromycine effects on
      paucisymptomatic patients with ou without co-morbidities
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    - Interest in the use of HCQ is controversial.
  </why_stopped>
  <start_date type="Anticipated">May 5, 2020</start_date>
  <completion_date type="Anticipated">July 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>open, interventional, multicentric study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvment or healing of clinical signs</measure>
    <time_frame>at the end of the study treatment - 1 month after inclusion</time_frame>
    <description>no respiratory infectious signs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution of clinical signs</measure>
    <time_frame>at the end of the study treatment - 1 month after inclusion</time_frame>
    <description>Low respiratory signs with severity criteria</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Patients With COVID19</condition>
  <arm_group>
    <arm_group_label>HCQ Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <description>400mg per day during 10 days</description>
    <arm_group_label>HCQ Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Azithromycin</intervention_name>
    <description>500 mg per day during 5 days</description>
    <arm_group_label>HCQ Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed COVID19 (+)

          -  Qt&lt;500ms

          -  no severity criteria

          -  pauci-symptomatique patients

          -  signed consent form

        Exclusion Criteria:

          -  no confirmed patient COVID19

          -  severity criteria

          -  known allegies to macrolides and HCQ

          -  Treated with HCQ within 1 month prior to inclusion

          -  hepatitis insufficiency

          -  Renal insufficiency

          -  treatment no indicated with azithro and HCQ

          -  hypovolemia

          -  complete brach block

          -  retinopathia

          -  psoriasis

          -  pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eshmoun Clinical Research Centre/ HÃ´pital Abderrahmen Mami-Ariana</name>
      <address>
        <city>Tunis</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>April 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Abderrahmane Mami Hospital</investigator_affiliation>
    <investigator_full_name>Dr Jalila Ben Khelil</investigator_full_name>
    <investigator_title>Head of department</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azithromycin</mesh_term>
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

